Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Porter

Showing results (351-360 of 764) with videos related to

Pageof 77
Sort By:
The Journal of Reproductive Medicine|September 28, 1998
Urine protein dipstick measurements. A screen for a standard, 24-hour urine collectionA Jazayeri, R A Chez, K B Porter, et al.
Water Science and Technology : a Journal of the International Association on Water Pollution Research|March 25, 2008
What drives communities' decisions and behaviours in the reuse of wastewaterB E Nancarrow, Z Leviston, M Po, et al.
Blood|May 23, 1998
Raised neutrophil phospholipase A2 activity and defective priming of NADPH oxidase and phospholipase A2 in sickle cell diseaseE Mollapour, J B Porter, R Kaczmarski, et al.
JAMA|December 21, 1984
Drug-induced blood disordersD A Danielson, S W Douglas, P Herzog, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|May 17, 2007
Epigallocatechin-3-gallate and epicatechin-3-gallate from green tea decrease plasma non-transferrin bound iron and erythrocyte oxidative stressC Thephinlap, S Ounjaijean, U Khansuwan, et al.
British Journal of Haematology|March 1, 1993
Sickle cell disorders and chronic intravascular haemolysis are associated with low plasma heparin cofactor IIJ B Porter, L Young, I J Mackie, et al.
Drug Design, Development and Therapy|December 24, 2016
Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromesAli T Taher, John B Porter, Antonis Kattamis, et al.
The American Journal of Tropical Medicine and Hygiene|June 3, 2011
Analysis of the cross-reactivity of various 56 kDa recombinant protein antigens with serum samples collected after Orientia tsutsugamushi infection by ELISAChien-Chung Chao, Erin S Huber, Terrisita B Porter, et al.
The Journal of Chemical Physics|July 11, 2006
Hyperfine spectrum of RbClJ Cederberg, S Fortman, B Porter, et al.
Lancet (London, England)|July 15, 1989
Animal toxicology of iron chelator L1J B Porter, K P Hoyes, R Abeysinghe, et al.
Pageof 77

Showing results (351-360 of 764) with videos related to

Sort By:
Pageof 77
The Journal of Reproductive Medicine|September 28, 1998
Urine protein dipstick measurements. A screen for a standard, 24-hour urine collectionA Jazayeri, R A Chez, K B Porter, et al.
Water Science and Technology : a Journal of the International Association on Water Pollution Research|March 25, 2008
What drives communities' decisions and behaviours in the reuse of wastewaterB E Nancarrow, Z Leviston, M Po, et al.
Blood|May 23, 1998
Raised neutrophil phospholipase A2 activity and defective priming of NADPH oxidase and phospholipase A2 in sickle cell diseaseE Mollapour, J B Porter, R Kaczmarski, et al.
JAMA|December 21, 1984
Drug-induced blood disordersD A Danielson, S W Douglas, P Herzog, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|May 17, 2007
Epigallocatechin-3-gallate and epicatechin-3-gallate from green tea decrease plasma non-transferrin bound iron and erythrocyte oxidative stressC Thephinlap, S Ounjaijean, U Khansuwan, et al.
British Journal of Haematology|March 1, 1993
Sickle cell disorders and chronic intravascular haemolysis are associated with low plasma heparin cofactor IIJ B Porter, L Young, I J Mackie, et al.
Drug Design, Development and Therapy|December 24, 2016
Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromesAli T Taher, John B Porter, Antonis Kattamis, et al.
The American Journal of Tropical Medicine and Hygiene|June 3, 2011
Analysis of the cross-reactivity of various 56 kDa recombinant protein antigens with serum samples collected after Orientia tsutsugamushi infection by ELISAChien-Chung Chao, Erin S Huber, Terrisita B Porter, et al.
The Journal of Chemical Physics|July 11, 2006
Hyperfine spectrum of RbClJ Cederberg, S Fortman, B Porter, et al.
Lancet (London, England)|July 15, 1989
Animal toxicology of iron chelator L1J B Porter, K P Hoyes, R Abeysinghe, et al.
Pageof 77